Evidence map›Paper›PMID 28806779›Full record

ArticlePLoS genetics2017

A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.

Michael Crompton, Tom Purnell, Hayley E Tyrer, Andrew Parker, Greg Ball, Rachel E Hardisty-Hughes, Richard Gale, Debbie Williams, Charlotte H Dean, Michelle M Simon and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019.International journal of pediatric otorhinolaryngology · 2020
    Review
  14. Panel 2- recent advance in otitis media bioinformatics.International journal of pediatric otorhinolaryngology · 2020
    Review
  15. Panel 1: Biotechnology, biomedical engineering and new models of otitis media.International journal of pediatric otorhinolaryngology · 2020
    Review
  16. Panel 3: Genomics, precision medicine and targeted therapies.International journal of pediatric otorhinolaryngology · 2020
    Review
  17. Review
  18. Mutation inFrontiers in genetics · 2020
    Article
  19. TheFrontiers in genetics · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Michael CromptonMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0001-6463-9020
Tom PurnellMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Hayley E TyrerMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0002-4447-828X
Andrew ParkerMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Greg BallMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Rachel E Hardisty-HughesMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0003-0635-8073
Richard GaleMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Debbie WilliamsMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Charlotte H DeanMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0002-8846-5472
Michelle M SimonMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Ann-Marie MallonMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Sara WellsMary Lyon Centre, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0002-0572-0600
Mahmood F BhuttaMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.
Martin J BurtonNuffield Department of Surgical Sciences, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Hilda TateossianMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0001-7013-5806
Steve D M BrownMammalian Genetics Unit, MRC Harwell Institute, Harwell, Oxfordshire, United Kingdom.ORCID http://orcid.org/0000-0002-0617-4824
Mary Lyon Centre at MRC Harwell · GBUniversity of Oxford · GBSt John of God Subiaco Hospital · AU

Funding

Medical Research Council MC_U142684171Medical Research Council MC_U142684175Medical Research Council MC_UP_1502/1Wellcome Trust
6 · The paper itself

Abstract

Otitis media (OM), inflammation of the middle ear (ME), is a common cause of conductive hearing impairment. Despite the importance of the disease, the aetiology of chronic and recurrent forms of middle ear inflammatory disease remains poorly understood. Studies of the human population suggest that there is a significant genetic component predisposing to the development of chronic OM, although the underlying genes are largely unknown. Using N-ethyl-N-nitrosourea mutagenesis we identified a recessive mouse mutant, edison, that spontaneously develops a conductive hearing loss due to chronic OM. The causal mutation was identified as a missense change, L972P, in the Nischarin (NISCH) gene. edison mice develop a serous or granulocytic effusion, increasingly macrophage and neutrophil rich with age, along with a thickened, inflamed mucoperiosteum. We also identified a second hypomorphic allele, V33A, with only modest increases in auditory thresholds and reduced incidence of OM. NISCH interacts with several proteins, including ITGA5 that is thought to have a role in modulating VEGF-induced angiogenesis and vascularization. We identified a significant genetic interaction between Nisch and Itga5; mice heterozygous for Itga5-null and homozygous for edison mutations display a significantly increased penetrance and severity of chronic OM. In order to understand the pathological mechanisms underlying the OM phenotype, we studied interacting partners to NISCH along with downstream signalling molecules in the middle ear epithelia of edison mouse. Our analysis implicates PAK1 and RAC1, and downstream signalling in LIMK1 and NF-κB pathways in the development of chronic OM.

Indexed as

Mutation, MissenseAllelesAnimalsChromosome MappingChronic DiseaseDisease Models, AnimalEar, MiddleEthylnitrosoureaFemaleGenotyping TechniquesHeterozygoteHomozygoteHumansImidazoline ReceptorsInflammationIntegrin alpha6EthylnitrosoureaImidazoline ReceptorsIntegrin alpha6Intracellular Signaling Peptides and ProteinsLimk1 protein, mouseLim KinasesNeuropeptidesNF-kappa BNisch protein, mousep21-Activated KinasesPak1 protein, mouserac1 GTP-Binding ProteinRac1 protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID28806779
PMCPMC5570507
OpenAlexW2745707421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.